Enzene Inc.

Enzene Inc.

Exhibitors

Information

Enzene an integrated global CDMO, offers services spanning discovery, development and commercial supply. Its patented fully-connected continuous manufacturing(TM) (FCCM(TM)) platform, EnzeneX(TM), is validated for commercial biologics supply and demonstrates significantly increased production yields and reduced costs. Enzene aims to lower mAb production costs below $40/gram by 2025. Our microbial and mammalian drug substance plants, as well as our sterile fill & finish plant in India are EU-GMP certified.Visit www.enzene.com.
Organization Type
CMO/CDMO
Country/Region
United States
Business Activity
Animal HealthBiopharmaceuticalContract Manufacturer
Markets Active In
North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)
Products and Services
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Innovative APIsLaboratory and Analytical ServicesBiopharmaceutical Services
Company Certification
OtherISOGMP
Product Types
Biopharmaceutical ProductsInnovative APIs
Service Types
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Laboratory and Analytical ServicesBiopharmaceutical Services
Product Categories
  • Innovative APIs
    • Peptides
    Service Categories
    • Laboratory and Analytical Services
      • Method Development
        • Method Validation
        • Biopharmaceutical Services
          • Analytical Chemistry (Biopharmaceutical Services)

          Social media

          Contact details

          www.enzene.com
          United States

          Sessions

          EnzeneX® - An Innovation that Became an Industry Imperative

          Tuesday, October 6, 2026 3:15 PM to 3:40 PM
          Next-Gen Bio Theatre | 12F49
          Shilpa Gadgil · Enzene

          From At‑Risk to Accelerated: How Enzene Redefines Biologics Development

          Tuesday, October 6, 2026 6:30 PM to 8:30 PM
          Supply & Formulation Excellence Theatre | 2A132

          Join the Taste of Italy Tour

          Wednesday, October 7, 2026 5:00 PM to 8:00 PM

          Enzene - Taste of Italy Tour

          222 seats left
          Wednesday, October 7, 2026 5:00 PM to 8:00 PM
          12C57

          Team

          Shilpa Gadgil
          Shilpa Gadgil
          VP, Head of Bioprocess and CDMO DevelopmentEnzene

          Join the event!

          See all the content and easy-to-use features by logging in or registering!